USEFUL LINKS

VETMEDIN dosage

VETMEDIN is easy to administer for improved client compliance

Supplied in 4 sizes

Help you ensure accurate dosing
Encourage ongoing compliance
Give owners choices that are both effective and cost-effective

Palatable chewable tablets

Half-scored for easy, accurate dosing
Highly palatable for dogs
- In a US Good Laboratory Practice (GLP) palatability study, 90% (18 of 20) dogs voluntarily consumed greater than 70% of the tablets offered.^1,2
- Including 2 dogs that consumed only 4% and 7% of the tablets offered, the average voluntary consumption was 84.2%.^1,2

Convenient packaging

Supplied in 50-count bottles

Easy to administer

VETMEDIN should be administered orally at a total daily dose of 0.23 mg/lb (0.5 mg/kg) of body weight using a suitable combination of whole or half tablets. The total daily dose should be divided into two portions that are not necessarily equal, and the portions should be given approximately 12 hours apart (ie, morning and evening). The tablets are scored, and the calculated daily dosage should be provided to the nearest half-tablet increment.

VETMEDIN Dosage Chart

The examples given in the dosage chart do not necessarily depict the only way to provide the correct dose. Other combinations of whole and half tablets may also be appropriate.

Click here for downloadable PDF of VETMEDIN Dosage Chart.

Important safety information

The safety of VETMEDIN has not been established in dogs with:

Asymptomatic heart disease
Heart failure caused by etiologies other than atrioventricular valvular insufficiency or dilated cardiomyopathy
Dogs younger than 6 months of age
Dogs with congenital heart defects
Dogs with diabetes mellitus or other serious metabolic diseases
Dogs used for breeding or pregnant or lactating bitches

* All doses provided as tablets.

References:

1. VETMEDIN^® (pimobendan) Chewable Tablets [package insert]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2007. 2. VETMEDIN^® (pimobendan) Chewable Tablets [Freedom of Information Summary]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2007.

Important safety information

VETMEDIN should not be given in case of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. The safety of VETMEDIN has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than atrioventricularvalvular insufficiency or dilated cardiomyopathy. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Use only in dogs with clinical evidence of heart failure. The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia. If side effects should occur, pet owners should contact their veterinarian. Please refer to the Full Prescribing Information here.